BRISTOL-MYERS SQUIBB CO (BMY) Fundamental Analysis & Valuation
NYSE:BMY • US1101221083
Current stock price
58.8 USD
-0.59 (-0.99%)
At close:
58.74 USD
-0.06 (-0.1%)
Pre-Market:
This BMY fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. BMY Profitability Analysis
1.1 Basic Checks
- In the past year BMY was profitable.
- In the past year BMY had a positive cash flow from operations.
- Of the past 5 years BMY 4 years were profitable.
- In the past 5 years BMY always reported a positive cash flow from operatings.
1.2 Ratios
- Looking at the Return On Assets, with a value of 7.83%, BMY belongs to the top of the industry, outperforming 88.48% of the companies in the same industry.
- Looking at the Return On Equity, with a value of 38.19%, BMY belongs to the top of the industry, outperforming 96.86% of the companies in the same industry.
- Looking at the Return On Invested Capital, with a value of 19.52%, BMY belongs to the top of the industry, outperforming 95.81% of the companies in the same industry.
- Measured over the past 3 years, the Average Return On Invested Capital for BMY is in line with the industry average of 13.11%.
- The last Return On Invested Capital (19.52%) for BMY is above the 3 year average (14.47%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.83% | ||
| ROE | 38.19% | ||
| ROIC | 19.52% |
ROA(3y)2.2%
ROA(5y)3.91%
ROE(3y)3.56%
ROE(5y)10.1%
ROIC(3y)14.47%
ROIC(5y)12.91%
1.3 Margins
- BMY has a better Profit Margin (14.64%) than 87.96% of its industry peers.
- In the last couple of years the Profit Margin of BMY has grown nicely.
- The Operating Margin of BMY (35.82%) is better than 96.34% of its industry peers.
- In the last couple of years the Operating Margin of BMY has grown nicely.
- BMY's Gross Margin of 72.63% is amongst the best of the industry. BMY outperforms 80.10% of its industry peers.
- BMY's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 35.82% | ||
| PM (TTM) | 14.64% | ||
| GM | 72.63% |
OM growth 3Y13.23%
OM growth 5Y20.59%
PM growth 3Y2.21%
PM growth 5YN/A
GM growth 3Y-2.43%
GM growth 5Y-0.33%
2. BMY Health Analysis
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so BMY is creating value.
- Compared to 1 year ago, BMY has more shares outstanding
- BMY has less shares outstanding than it did 5 years ago.
- The debt/assets ratio for BMY has been reduced compared to a year ago.
2.2 Solvency
- An Altman-Z score of 2.52 indicates that BMY is not a great score, but indicates only limited risk for bankruptcy at the moment.
- With a decent Altman-Z score value of 2.52, BMY is doing good in the industry, outperforming 62.83% of the companies in the same industry.
- The Debt to FCF ratio of BMY is 3.51, which is a good value as it means it would take BMY, 3.51 years of fcf income to pay off all of its debts.
- BMY has a Debt to FCF ratio of 3.51. This is amongst the best in the industry. BMY outperforms 89.01% of its industry peers.
- BMY has a Debt/Equity ratio of 2.33. This is a high value indicating a heavy dependency on external financing.
- The Debt to Equity ratio of BMY (2.33) is worse than 81.68% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.33 | ||
| Debt/FCF | 3.51 | ||
| Altman-Z | 2.52 |
ROIC/WACC2.2
WACC8.87%
2.3 Liquidity
- BMY has a Current Ratio of 1.26. This is a normal value and indicates that BMY is financially healthy and should not expect problems in meeting its short term obligations.
- BMY's Current ratio of 1.26 is on the low side compared to the rest of the industry. BMY is outperformed by 80.10% of its industry peers.
- A Quick Ratio of 1.14 indicates that BMY should not have too much problems paying its short term obligations.
- BMY has a Quick ratio of 1.14. This is in the lower half of the industry: BMY underperforms 78.01% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.26 | ||
| Quick Ratio | 1.14 |
3. BMY Growth Analysis
3.1 Past
- The Earnings Per Share has grown by an impressive 439.47% over the past year.
- Measured over the past years, BMY shows a decrease in Earnings Per Share. The EPS has been decreasing by -0.92% on average per year.
- Looking at the last year, BMY shows a decrease in Revenue. The Revenue has decreased by -0.22% in the last year.
- The Revenue has been growing slightly by 2.54% on average over the past years.
EPS 1Y (TTM)439.47%
EPS 3Y-7.62%
EPS 5Y-0.92%
EPS Q2Q%-24.55%
Revenue 1Y (TTM)-0.22%
Revenue growth 3Y1.45%
Revenue growth 5Y2.54%
Sales Q2Q%1.3%
3.2 Future
- BMY is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -4.15% yearly.
- The Revenue is expected to decrease by -5.54% on average over the next years.
EPS Next Y2.96%
EPS Next 2Y0.32%
EPS Next 3Y-4.23%
EPS Next 5Y-4.15%
Revenue Next Year-1.82%
Revenue Next 2Y-2.01%
Revenue Next 3Y-5.44%
Revenue Next 5Y-5.54%
3.3 Evolution
- The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. BMY Valuation Analysis
4.1 Price/Earnings Ratio
- The Price/Earnings ratio is 9.56, which indicates a very decent valuation of BMY.
- BMY's Price/Earnings ratio is rather cheap when compared to the industry. BMY is cheaper than 92.67% of the companies in the same industry.
- BMY is valuated cheaply when we compare the Price/Earnings ratio to 27.79, which is the current average of the S&P500 Index.
- A Price/Forward Earnings ratio of 9.29 indicates a reasonable valuation of BMY.
- 89.01% of the companies in the same industry are more expensive than BMY, based on the Price/Forward Earnings ratio.
- BMY's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 38.88.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.56 | ||
| Fwd PE | 9.29 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, BMY is valued cheaper than 93.19% of the companies in the same industry.
- Based on the Price/Free Cash Flow ratio, BMY is valued cheaply inside the industry as 92.67% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 9.35 | ||
| EV/EBITDA | 7.23 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
- BMY has an outstanding profitability rating, which may justify a higher PE ratio.
- BMY's earnings are expected to decrease with -4.23% in the coming years. This may justify a cheaper valuation.
PEG (NY)3.23
PEG (5Y)N/A
EPS Next 2Y0.32%
EPS Next 3Y-4.23%
5. BMY Dividend Analysis
5.1 Amount
- With a Yearly Dividend Yield of 4.27%, BMY is a good candidate for dividend investing.
- Compared to an average industry Dividend Yield of 0.68, BMY pays a better dividend. On top of this BMY pays more dividend than 96.34% of the companies listed in the same industry.
- BMY's Dividend Yield is rather good when compared to the S&P500 average which is at 1.81.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.27% |
5.2 History
- The dividend of BMY is nicely growing with an annual growth rate of 6.51%!
- BMY has been paying a dividend for at least 10 years, so it has a reliable track record.
- BMY has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)6.51%
Div Incr Years4
Div Non Decr Years4
5.3 Sustainability
- 71.52% of the earnings are spent on dividend by BMY. This is not a sustainable payout ratio.
- The Dividend Rate of BMY has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
DP71.52%
EPS Next 2Y0.32%
EPS Next 3Y-4.23%
BMY Fundamentals: All Metrics, Ratios and Statistics
58.8
-0.59 (-0.99%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-05 2026-02-05/bmo
Earnings (Next)04-30 2026-04-30
Inst Owners83.83%
Inst Owner Change0.64%
Ins Owners0.03%
Ins Owner Change1.98%
Market Cap120.05B
Revenue(TTM)48.19B
Net Income(TTM)7.05B
Analysts70.56
Price Target63.21 (7.5%)
Short Float %1.54%
Short Ratio2.37
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.27% |
Yearly Dividend2.51
Dividend Growth(5Y)6.51%
DP71.52%
Div Incr Years4
Div Non Decr Years4
Ex-Date04-02 2026-04-02 (0.63)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.39%
Min EPS beat(2)6.92%
Max EPS beat(2)11.85%
EPS beat(4)4
Avg EPS beat(4)18.29%
Min EPS beat(4)6.92%
Max EPS beat(4)35.04%
EPS beat(8)8
Avg EPS beat(8)16.75%
EPS beat(12)11
Avg EPS beat(12)12.26%
EPS beat(16)15
Avg EPS beat(16)10.82%
Revenue beat(2)2
Avg Revenue beat(2)1.61%
Min Revenue beat(2)0.79%
Max Revenue beat(2)2.43%
Revenue beat(4)4
Avg Revenue beat(4)3.42%
Min Revenue beat(4)0.79%
Max Revenue beat(4)6.79%
Revenue beat(8)8
Avg Revenue beat(8)3.86%
Revenue beat(12)9
Avg Revenue beat(12)1.94%
Revenue beat(16)12
Avg Revenue beat(16)1.77%
PT rev (1m)1.9%
PT rev (3m)11.07%
EPS NQ rev (1m)-1.66%
EPS NQ rev (3m)-0.94%
EPS NY rev (1m)-0.02%
EPS NY rev (3m)4.46%
Revenue NQ rev (1m)0.09%
Revenue NQ rev (3m)3.34%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)6.73%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.56 | ||
| Fwd PE | 9.29 | ||
| P/S | 2.49 | ||
| P/FCF | 9.35 | ||
| P/OCF | 8.48 | ||
| P/B | 6.5 | ||
| P/tB | N/A | ||
| EV/EBITDA | 7.23 |
EPS(TTM)6.15
EY10.46%
EPS(NY)6.33
Fwd EY10.77%
FCF(TTM)6.29
FCFY10.7%
OCF(TTM)6.93
OCFY11.79%
SpS23.6
BVpS9.05
TBVpS-10.96
PEG (NY)3.23
PEG (5Y)N/A
Graham Number35.3832 (-39.82%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.83% | ||
| ROE | 38.19% | ||
| ROCE | 25.91% | ||
| ROIC | 19.52% | ||
| ROICexc | 23.22% | ||
| ROICexgc | 84.94% | ||
| OM | 35.82% | ||
| PM (TTM) | 14.64% | ||
| GM | 72.63% | ||
| FCFM | 26.65% |
ROA(3y)2.2%
ROA(5y)3.91%
ROE(3y)3.56%
ROE(5y)10.1%
ROIC(3y)14.47%
ROIC(5y)12.91%
ROICexc(3y)17.24%
ROICexc(5y)15.38%
ROICexgc(3y)72.12%
ROICexgc(5y)85.46%
ROCE(3y)19.19%
ROCE(5y)17.14%
ROICexgc growth 3Y-3.78%
ROICexgc growth 5Y13.73%
ROICexc growth 3Y21.19%
ROICexc growth 5Y33.96%
OM growth 3Y13.23%
OM growth 5Y20.59%
PM growth 3Y2.21%
PM growth 5YN/A
GM growth 3Y-2.43%
GM growth 5Y-0.33%
F-Score7
Asset Turnover0.54
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.33 | ||
| Debt/FCF | 3.51 | ||
| Debt/EBITDA | 2.03 | ||
| Cap/Depr | 32.69% | ||
| Cap/Sales | 2.72% | ||
| Interest Coverage | 8.22 | ||
| Cash Conversion | 66.54% | ||
| Profit Quality | 182.1% | ||
| Current Ratio | 1.26 | ||
| Quick Ratio | 1.14 | ||
| Altman-Z | 2.52 |
F-Score7
WACC8.87%
ROIC/WACC2.2
Cap/Depr(3y)19.36%
Cap/Depr(5y)15.61%
Cap/Sales(3y)2.66%
Cap/Sales(5y)2.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)439.47%
EPS 3Y-7.62%
EPS 5Y-0.92%
EPS Q2Q%-24.55%
EPS Next Y2.96%
EPS Next 2Y0.32%
EPS Next 3Y-4.23%
EPS Next 5Y-4.15%
Revenue 1Y (TTM)-0.22%
Revenue growth 3Y1.45%
Revenue growth 5Y2.54%
Sales Q2Q%1.3%
Revenue Next Year-1.82%
Revenue Next 2Y-2.01%
Revenue Next 3Y-5.44%
Revenue Next 5Y-5.54%
EBIT growth 1Y49.54%
EBIT growth 3Y14.87%
EBIT growth 5Y23.65%
EBIT Next Year23.35%
EBIT Next 3Y2.42%
EBIT Next 5Y-1.47%
FCF growth 1Y-7.87%
FCF growth 3Y2.44%
FCF growth 5Y-0.69%
OCF growth 1Y-6.81%
OCF growth 3Y2.71%
OCF growth 5Y0.15%
BRISTOL-MYERS SQUIBB CO / BMY Fundamental Analysis FAQ
What is the ChartMill fundamental rating of BRISTOL-MYERS SQUIBB CO (BMY) stock?
ChartMill assigns a fundamental rating of 6 / 10 to BMY.
What is the valuation status for BMY stock?
ChartMill assigns a valuation rating of 8 / 10 to BRISTOL-MYERS SQUIBB CO (BMY). This can be considered as Undervalued.
How profitable is BRISTOL-MYERS SQUIBB CO (BMY) stock?
BRISTOL-MYERS SQUIBB CO (BMY) has a profitability rating of 9 / 10.
What is the valuation of BRISTOL-MYERS SQUIBB CO based on its PE and PB ratios?
The Price/Earnings (PE) ratio for BRISTOL-MYERS SQUIBB CO (BMY) is 9.56 and the Price/Book (PB) ratio is 6.5.
What is the earnings growth outlook for BRISTOL-MYERS SQUIBB CO?
The Earnings per Share (EPS) of BRISTOL-MYERS SQUIBB CO (BMY) is expected to grow by 2.96% in the next year.